Cuprina Holdings (Cayman) Limited filed a Form 6-K with the SEC on October 2, 2026, detailing significant acquisition agreements that could reshape its business operations. This filing is crucial for investors and stakeholders as it highlights the company's strategic direction and potential growth in the healthcare sector.
Background on Cuprina Holdings
Cuprina Holdings is an investment company based in Singapore, focusing on orthopedic, prosthetic, and surgical appliances and supplies. The company is incorporated in the Cayman Islands and operates through its subsidiaries, including Cuprina Holdings (BVI) Limited.
The Form 6-K is a report used by foreign companies to disclose important information to the SEC, particularly when they are not required to file regular reports. This form allows companies like Cuprina to keep investors informed about significant events.
Details from the Filing
The filing reveals that on October 1, 2026, Cuprina Holdings (BVI) Limited, a wholly-owned subsidiary, entered into two sale and purchase agreements:
(i) A sale and purchase agreement (SPA I) to acquire 20,000 ordinary shares in East Coast Podiatry Centre Pte. Ltd. and 60,000 ordinary shares in Orchard Clinic Management Pte. Ltd.
(ii) A second sale and purchase agreement (SPA II) for an additional 80,000 ordinary shares in East Coast Podiatry Centre and 240,000 ordinary shares in Orchard Clinic Management.
The total consideration for these acquisitions is approximately S$4.0 million, structured as follows:
- For Sale Shares I: Cash payments totaling S$0.6 million and issuance of 60,334 consideration shares.
- For Sale Shares II: Cash payments totaling S$2.4 million and issuance of 241,337 consideration shares.
These transactions are subject to shareholder approval at an Extraordinary General Meeting scheduled for October 15, 2026. Completion of the deals is expected by November 1, 2026, pending this approval.
Impact of the Acquisition
This acquisition could significantly impact Cuprina Holdings' market position in the healthcare sector, particularly in podiatry and women's health services. By acquiring East Coast Podiatry Centre and Orchard Clinic Management, the company aims to enhance its service offerings and expand its operational footprint in Singapore.
The acquisition may also affect various stakeholders, including existing shareholders, employees of the acquired companies, and patients who utilize the services of these clinics. The integration of these clinics into Cuprina's operations could lead to improved healthcare services and increased market competitiveness.
What's Next?
The filing indicates that the next steps involve seeking shareholder approval for the increase in authorized share capital to facilitate the acquisition. The Extraordinary General Meeting will be held on October 15, 2026, where shareholders will vote on the proposed changes.
Completion of the acquisition is anticipated shortly after the meeting, provided the necessary approvals are granted. After the completion, East Coast Podiatry Centre and Orchard Clinic Management will become wholly-owned subsidiaries of Cuprina Holdings.











